Items related to Antiviral Chemotherapy 5: New Directions for Clinical...
Antiviral Chemotherapy 5: New Directions for Clinical Application and Research (Advances in Experimental Medicine and Biology, 458) - Hardcover
Synopsis
Scientists and clinicians attending the last "New Directions in Antiviral Therapy" conference in late 1994 could hardly have predicted the revolution in the management of patients with HIV infection that has occurred since. Two new classes of antiretrovirals have been licensed, the second-site RT inhibitors and the protease inhibitors; the long in cubation period of active HIV infection, when the infection is clinically latent, is now un derstood to be a period of intense viral replication and turnover of CD4 lymphocytes; measurements of HI V RNA concentration in plasma have been shown to be essential tools for monitoring the course of HIV infection, deciding when to treat, and assessing the re sults of treatment; and finally, combinations of antiretrovirals, particularly combinations including protease inhibitors, have been shown to have dramatically beneficial effects on patients with HIV infection. These advances, coupled with new drugs for the management of herpesvirus infections, have made dramatic differences in the quality and length of life of HIV-infected patients. Additional advances have been made since 1994 in the prevention or management of influenza virus (zanamavir), respiratory syncytial virus (palvizumab), hepatitis B virus (lamivudine and famciclovir), and enterovirus infections (pleconaril). It is difficult to re member that only slightly more than a decade ago there were only a handful of antiviral agents available (none of which were antiretrovirals), and a number of those were either highly toxic, of dubious efficacy, or both.
"synopsis" may belong to another edition of this title.
- PublisherSpringer
- Publication date1999
- ISBN 10 0306461072
- ISBN 13 9780306461071
- BindingHardcover
- Number of pages279
- EditorMills John, Volberding Paul A., Corey Lawrence
Buy New
Learn more about this copy
US$ 169.66
Shipping:
FREE
Within U.S.A.
Top Search Results from the AbeBooks Marketplace
Stock Image
Antiviral Chemotherapy 5. New Directions for Clinical Application and Research
Published by
Kluwer Academic/Plenum Publishers, c1999., New York, 1999
ISBN 10: 0306461072
ISBN 13: 9780306461071
Used
Hardcover
Seller: Research Ink, Takoma Park, MD, U.S.A.
Seller rating 4 out of 5 stars
Hardback. Condition: Very Good. viii + 271 pp. Advances in Experimental Medicine and Biology5. Rubber-stamped on front free endpaper. book. Seller Inventory # 10543
Quantity: 1 available
Stock Image
Antiviral Chemotherapy 5: New Directions for Clinical Application and Research [Advances in Experimental Medicine and Biology, Volume 458]
Published by
Kluwer Academic / Plenum Publishers, New York., 1999
ISBN 10: 0306461072
ISBN 13: 9780306461071
Used
Hardcover
Seller: Tiber Books, Cockeysville, MD, U.S.A.
Seller rating 5 out of 5 stars
Hardcover. Condition: Very Good. 8vo, hardcover. No dj, as issued. Vg condition. Non-circulating ex-lib copy w/ label inside cover, exterior labels neatly removed (only markings); contents quite bright & clean, binding tight, covers glossy. viii, 271 p., illus. Proceedings of the Fifth Triennial Symposium on New Directions in Antiviral Chemotherapy, held November 13-15, 1997, in San Francisco, CA. Seller Inventory # 1121022.07
Quantity: 1 available
Seller Image
Antiviral Chemotherapy 5: New Directions for Clinical Application and Research (Advances in Experimental Medicine and Biology) (v. 5) [Hardcover ]
Seller: booksXpress, Bayonne, NJ, U.S.A.
Seller rating 4 out of 5 stars
Hardcover. Condition: new. Seller Inventory # 9780306461071
Quantity: 10 available
Seller Image
Antiviral Chemotherapy 5 : New Directions for Clinical Application and Research
Seller: GreatBookPrices, Columbia, MD, U.S.A.
Seller rating 5 out of 5 stars
Condition: New. Seller Inventory # 659434-n
Quantity: 5 available
Stock Image
Antiviral Chemotherapy 5: New Directions for Clinical Application and Research (Advances in Experimental Medicine and Biology, 458)
Seller: Lucky's Textbooks, Dallas, TX, U.S.A.
Seller rating 5 out of 5 stars
Condition: New. Seller Inventory # ABLIING23Feb2215580099865
Quantity: Over 20 available
Stock Image
Antiviral Chemotherapy 5: New Directions for Clinical Applications and Research
Print on DemandSeller: Ria Christie Collections, Uxbridge, United Kingdom
Seller rating 5 out of 5 stars
Condition: New. PRINT ON DEMAND Book; New; Fast Shipping from the UK. No. book. Seller Inventory # ria9780306461071_lsuk
Quantity: Over 20 available
Seller Image
Antiviral Chemotherapy 5 : New Directions for Clinical Application and Research
Seller: GreatBookPricesUK, Castle Donington, DERBY, United Kingdom
Seller rating 5 out of 5 stars
Condition: New. Seller Inventory # 659434-n
Quantity: 5 available
Seller Image
Antiviral Chemotherapy 5
Print on DemandSeller: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germany
Seller rating 5 out of 5 stars
Buch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Scientists and clinicians attending the last 'New Directions in Antiviral Therapy' conference in late 1994 could hardly have predicted the revolution in the management of patients with HIV infection that has occurred since. Two new classes of antiretrovirals have been licensed, the second-site RT inhibitors and the protease inhibitors; the long in cubation period of active HIV infection, when the infection is clinically latent, is now un derstood to be a period of intense viral replication and turnover of CD4 lymphocytes; measurements of HI V RNA concentration in plasma have been shown to be essential tools for monitoring the course of HIV infection, deciding when to treat, and assessing the re sults of treatment; and finally, combinations of antiretrovirals, particularly combinations including protease inhibitors, have been shown to have dramatically beneficial effects on patients with HIV infection. These advances, coupled with new drugs for the management of herpesvirus infections, have made dramatic differences in the quality and length of life of HIV-infected patients. Additional advances have been made since 1994 in the prevention or management of influenza virus (zanamavir), respiratory syncytial virus (palvizumab), hepatitis B virus (lamivudine and famciclovir), and enterovirus infections (pleconaril). It is difficult to re member that only slightly more than a decade ago there were only a handful of antiviral agents available (none of which were antiretrovirals), and a number of those were either highly toxic, of dubious efficacy, or both. 282 pp. Englisch. Seller Inventory # 9780306461071
Quantity: 2 available
Seller Image
Antiviral Chemotherapy 5
Print on DemandSeller: moluna, Greven, Germany
Seller rating 5 out of 5 stars
Gebunden. Condition: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Scientists and clinicians attending the last New Directions in Antiviral Therapy conference in late 1994 could hardly have predicted the revolution in the management of patients with HIV infection that has occurred since. Two new classes of antiretroviral. Seller Inventory # 5902930
Quantity: Over 20 available
Seller Image
Antiviral Chemotherapy 5 : New Directions for Clinical Application and Research
Seller: AHA-BUCH GmbH, Einbeck, Germany
Seller rating 5 out of 5 stars
Buch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - Scientists and clinicians attending the last 'New Directions in Antiviral Therapy' conference in late 1994 could hardly have predicted the revolution in the management of patients with HIV infection that has occurred since. Two new classes of antiretrovirals have been licensed, the second-site RT inhibitors and the protease inhibitors; the long in cubation period of active HIV infection, when the infection is clinically latent, is now un derstood to be a period of intense viral replication and turnover of CD4 lymphocytes; measurements of HI V RNA concentration in plasma have been shown to be essential tools for monitoring the course of HIV infection, deciding when to treat, and assessing the re sults of treatment; and finally, combinations of antiretrovirals, particularly combinations including protease inhibitors, have been shown to have dramatically beneficial effects on patients with HIV infection. These advances, coupled with new drugs for the management of herpesvirus infections, have made dramatic differences in the quality and length of life of HIV-infected patients. Additional advances have been made since 1994 in the prevention or management of influenza virus (zanamavir), respiratory syncytial virus (palvizumab), hepatitis B virus (lamivudine and famciclovir), and enterovirus infections (pleconaril). It is difficult to re member that only slightly more than a decade ago there were only a handful of antiviral agents available (none of which were antiretrovirals), and a number of those were either highly toxic, of dubious efficacy, or both. Seller Inventory # 9780306461071
Quantity: 1 available